Literature DB >> 1672797

Central sympathoinhibition and peripheral neuronal uptake blockade after desipramine in rabbits.

G Eisenhofer1, T Saigusa, M D Esler, H S Cox, J A Angus, P K Dorward.   

Abstract

Peripheral- and central nervous system (CNS)-mediated effects of desipramine (Des) on sympathetic nerves and the contribution of alpha 2-adrenoceptors to these effects were studied in conscious rabbits. Blood pressure, renal sympathetic nerve activity (SNA), and norepinephrine (NE) reuptake and spillover into plasma were measured before and after intracisternal (ic) or intravenous (i.v.) administration of Des. In other animals, NE spillover responses to i.v. Des were examined before and after alpha 2-adrenoceptor blockade with i.v. idazoxan. Treatment with i.v. Des blocked neuronal reuptake and decreased renal SNA but did not alter blood pressure or NE spillover. Decreased NE release by sympathetic nerves after i.v. Des was reflected by a decrease in the combined rate of NE reuptake and spillover. Treatment with ic Des (at 1.7% of the i.v. dose) decreased blood pressure and renal SNA and produced equivalent falls in NE reuptake and spillover, indicating little peripheral effect of centrally administered Des on the efficiency of neuronal reuptake. Thus Des had two distinct actions: the drug blocked neuronal reuptake by direct actions on nerve endings and reduced SNA by actions within the CNS. After ic Des, decreased SNA produced parallel falls in NE reuptake, spillover, and blood pressure. After i.v. Des, blockade of neurotransmitter reuptake increased NE concentrations at sympathoeffector junctions offsetting the fall in SNA, so that there was little change in NE spillover or blood pressure. However, after alpha 2-adrenoceptor blockade with i.v. idazoxan, NE spillover increased in response to i.v. Des. Thus the Des-induced decrease in NE release was partly mediated by an action of raised intrasynaptic NE concentrations on inhibitory alpha 2-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672797     DOI: 10.1152/ajpregu.1991.260.4.R824

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Synergistic effect of norepinephrine transporter blockade and α-2 antagonism on blood pressure in autonomic failure.

Authors:  Luis E Okamoto; Cyndya Shibao; Alfredo Gamboa; Leena Choi; André Diedrich; Satish R Raj; Bonnie K Black; David Robertson; Italo Biaggioni
Journal:  Hypertension       Date:  2012-02-06       Impact factor: 10.190

2.  Synergistic Pressor Effect of Atomoxetine and Pyridostigmine in Patients With Neurogenic Orthostatic Hypotension.

Authors:  Luis E Okamoto; Cyndya A Shibao; Alfredo Gamboa; André Diedrich; Satish R Raj; Bonnie K Black; David Robertson; Italo Biaggioni
Journal:  Hypertension       Date:  2019-01       Impact factor: 10.190

3.  Stimulation of catecholamine synthesis via activation of p44/42 MAPK in cultured bovine adrenal medullary cells by milnacipran.

Authors:  Koji Shinkai; Yumiko Toyohira; Reiji Yoshimura; Masato Tsutsui; Susume Ueno; Jun Nakamura; Nobuyuki Yanagihara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-09       Impact factor: 3.000

4.  The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit.

Authors:  B Friedgen; R Wölfel; H Russ; E Schömig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

5.  Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure.

Authors:  Andreas L Birkenfeld; Christoph Schroeder; Tobias Pischon; Jens Tank; Friedrich C Luft; Arya M Sharma; Jens Jordan
Journal:  Clin Auton Res       Date:  2005-06       Impact factor: 4.435

Review 6.  Sympathetic nerve function--assessment by radioisotope dilution analysis.

Authors:  Graeme Eisenhofer
Journal:  Clin Auton Res       Date:  2005-08       Impact factor: 4.435

7.  6-[18F]fluorodopamine positron emission tomographic scanning in the assessment of cardiac sympathoneural function--studies in normal humans.

Authors:  D S Goldstein; C Holmes; J E Stuhlmuller; J W Lenders; I J Kopin
Journal:  Clin Auton Res       Date:  1997-02       Impact factor: 4.435

8.  Inhibition of uptake 1 by (+)-oxaprotiline reveals a differential central regulation of noradrenaline and adrenaline release.

Authors:  B Szabo; T Auberle; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-09       Impact factor: 3.000

9.  Plasma Norepinephrine in Hypertensive Rats Reflects α(2)-Adrenoceptor Release Control Only When Re-Uptake is Inhibited.

Authors:  Torill Berg; Sven Ivar Walaas; Bjørg Åse Roberg; Trang Thi Huynh; Jørgen Jensen
Journal:  Front Neurol       Date:  2012-11-08       Impact factor: 4.003

10.  Heart rate variability in children with tricyclic antidepressant intoxication.

Authors:  Ener Cagri Dinleyici; Zubeyir Kilic; Sabiha Sahin; Rabia Tutuncu-Toker; Makbule Eren; Zeynel Abidin Yargic; Pelin Kosger; Birsen Ucar
Journal:  Cardiol Res Pract       Date:  2013-03-05       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.